Understanding CADPS: A Potential Drug Target and Biomarker (G8618)

Target Name: CADPS

NCBI ID: G8618

CADPS

Understanding CADPS: A Potential Drug Target and Biomarker

CADPS (CAPS1_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the CAPS family, which includes proteins that are involved in the regulation of cell signaling pathways. One of the key functions of CADPS is to regulate the activity of the protein kinase ALCATRO, which is involved in a variety of cellular processes, including cell signaling, cell division, and tissue growth.

CADPS is also known as human capacitor protein 1, or HCP1. It is a protein that is expressed in the heart, liver, kidney, and pancreas, among other tissues. It is also found in the placenta, which is the tissue that provides oxygen and nutrients to the developing fetus.

The discovery of CADPS as a potential drug target or biomarker has significant implications for the treatment of a variety of diseases. For example, CADPS has been shown to be involved in the regulation of cell signaling pathways, which can be a potential target for drugs that are designed to interfere with these signaling pathways. Additionally, the regulation of CADPS activity by the protein kinase ALCATRO can be disrupted by certain drugs, which may be used to treat diseases that are caused by the over-activity of this protein.

One of the challenges in studying CADPS is its complex structure. While it is known that CADPS is a protein that is involved in the regulation of cell signaling pathways, it is not clear exactly how this protein functions at the molecular level. This is because CADPS has a large number of potential binding sites, and it is not clear which of these sites are involved in its function. Further research is needed to fully understand the molecular mechanisms of CADPS function.

In addition to its potential as a drug target, CADPS is also being studied as a potential biomarker for a variety of diseases. For example, CADPS has been shown to be involved in the regulation of cell signaling pathways, which can be a potential target for drugs that are designed to interfere with these signaling pathways. This suggests that CADPS may be a useful biomarker for diseases that are caused by the over-activity of these signaling pathways. Additionally, the regulation of CADPS activity by the protein kinase ALCATRO can be disrupted by certain drugs, which may be used to treat diseases that are caused by the over-activity of this protein.

In conclusion, CADPS is a protein that is expressed in various tissues of the human body. It is a member of the CAPS family and is involved in the regulation of cell signaling pathways. The discovery of CADPS as a potential drug target or biomarker has significant implications for the treatment of a variety of diseases. Further research is needed to fully understand its molecular mechanisms of function and to develop treatments that can take advantage of its potential.

Protein Name: Calcium Dependent Secretion Activator

Functions: Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates catecholamine loading of DCVs. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles by acting as a PtdIns(4,5)P2-binding protein that acts at prefusion step following ATP-dependent priming and participates in DCVs-membrane fusion. However, it may also participate in small clear synaptic vesicles (SVs) exocytosis and it is unclear whether its function is related to Ca(2+) triggering (By similarity)

The "CADPS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CADPS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets